2m 2m 2m 2m 2m 2m 2m
BIOFRONTERA (BFRI)
NASDAQ
$0.75-$0.17 (-18.89%)
Price as of Nov 13, 2026 2:10 PM EST- $13.8MMarket Cap
- 4.02%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOFRONTERA (BFRI)
$0.75-$0.17 (-18.89%)
BFRI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.93 | ||
Change | -$0.01 (-1.24%) | ||
Open | $0.94 | ||
High | $0.94 | ||
Low | $0.91 | ||
Previous Close | $0.94 | ||
Volume | 131,588 | ||
30-Day Average Volume | 169,622 | ||
1-Week Change | 14.62% | ||
1-Month Change | 0.09% | ||
1-Year Change | 4.02% | ||
3-Year Change | -75.70% | ||
5-Year Change | -98.63% | ||
Fundamentals | |||
Shares Outstanding | 14.9M | ||
Total Assets | $24.1M | ||
Market Cap | $13.8M | ||
Enterprise Value | $13.7M | ||
Period: QTR TTM FY | |||
Revenue | $12.0M | ||
Net Income | N/A | ||
Free Cash Flow | -$1.7M | ||
EBIT | $149,000.00 | ||
EBITDA | $214,000.00 | ||
Net Working Capital | $1.9M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 1 | ||
P/B | N/A | ||
P/E | -19 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 07/05/2023 | ||
Earnings & Revenue